ArticleOncoTargets and therapy2017

Apatinib to combat EGFR-TKI resistance in an advanced non-small cell lung cancer patient with unknown EGFR status: a case report.

Yanmei Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.